"10.1371_journal.pone.0044580","none","2012-09-06T00:00:00Z","Nicole Bedke; David Sammut; Ben Green; Valia Kehagia; Patrick Dennison; Gisli Jenkins; Amanda Tatler; Peter H Howarth; Stephen T Holgate; Donna E Davies","Academic Unit of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, United Kingdom; National Institute for Health Research, Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, United Kingdom; University of Nottingham, Clinical Sciences Building, Nottingham City Hospital, Nottingham, United Kingdom","Conceived and designed the experiments: NB DED STH GJ. Performed the experiments: NB AT GJ. Analyzed the data: NB DED AT GJ. Contributed reagents/materials/analysis tools: GJ. Wrote the paper: NB DED STH GJ PHH. Recruiting normal and asthmatic volunteers: DS BG VK PD. Performing bronchospies: DS BG VK PD. Collecting bronchial brushings: DS BG VK PD.","DED and STH are co-founders of Synairgen Research Ltd. and hold shares in Synairgen plc. Synairgen is currently developing inhaled IFN-β for treatment of virus-induced asthma exacerbations. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.","2012","09","Nicole Bedke","NB",10,TRUE,4,3,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
